Zobrazeno 1 - 10
of 37
pro vyhledávání: '"József Barkóczy"'
Autor:
Lori-An Etherington, Adrienn Pálvölgyi, Katalin Pallagi, Ferenc A. Antoni, Adam R. Brown, József Barkóczy, Delia Belelli, Olivia Monteiro, Szabolcs Kertesz, Ben G. Gunn, Michael Spedding, Balázs Mihalik, Istvan Gacsalyi, István Ling, Matthew R. Livesey, Péter Varga, Jeremy J. Lambert
Publikováno v:
Etherington, L-A, Mihalik, B, Pálvölgyi, A, Ling, I, Pallagi, K, Kertész, S, Varga, P, Gunn, B, Brown, A, Livesey, M, Monteiro, O, Belelli, D, Barkóczy, J, Spedding, M, Gacsályi, I, Antoni, F & Lambert, J 2017, ' Selective inhibition of extra-synaptic α5-GABAA receptors by S44819, a new therapeutic agent. ', Neuropharmacology, pp. 30379-9 . https://doi.org/10.1016/j.neuropharm.2017.08.012
In the mammalian central nervous system (CNS) GABAA receptors (GABAARs) mediate neuronal inhibition and are important therapeutic targets. GABAARs are composed of 5 subunits, drawn from 19 proteins, underpinning expression of 20–30 GABAAR subtypes.
Autor:
Janos Wellmann, István Ling, Jeremy J. Lambert, Ferenc A. Antoni, József Haller, Krisztina Moricz, József Barkóczy, Katalin Nagy, Gábor Szénási, Gabor Gigler, Istvan Gacsalyi, Michael Spedding
Publikováno v:
Neuropharmacology. 125:30-38
Previous work has shown that S44819 is a novel GABAA receptor (GABAAR) antagonist, which is selective for extrasynaptic GABAARs incorporating the α5 subunit (α5-GABAARs). The present study reports on the preclinical neuropsychopharmacological profi
Autor:
Tamás A. Martinek, Istvan Gacsalyi, Katalin Megyeri, Ferenc Bogár, Adrienn Pálvölgyi, István Ling, Ferenc A. Antoni, Balázs Mihalik, Ferenc Bartha, József Barkóczy
Publikováno v:
European Journal of Pharmacology. 798:129-136
The neurotransmitter γ-amino butyric acid (GABA) has a fundamental role in CNS function and ionotropic (GABAA) receptors that mediate many of the actions of GABA are important therapeutic targets. This study reports the mechanism of action of novel
Autor:
Gyula Simig, Adrienn Pálvölgyi, Szabolcs Kertesz, István Ling, Istvan Gacsalyi, Éva Szabó, Attila Gaál, Michael Spedding, Balázs Mihalik, Gábor Szénási, Delia Belelli, Gabor Gigler, Jeremy J. Lambert, Péter Kiricsi, Lori An Etherington, Balázs Volk, József Barkóczy, Katalin Pallagi, Ferenc A. Antoni, György Lévay, Gábor Kapus, Lilla Papp, Laszlo G. Harsing
Publikováno v:
European Journal of Pharmacology. 764:497-507
Novel 2,3-benzodiazepine and related isoquinoline derivatives, substituted at position 1 with a 2-benzothiophenyl moiety, were synthesized to produce compounds that potently inhibited the action of GABA on heterologously expressed GABAA receptors con
Autor:
István, Gacsályi, Krisztina, Móricz, Gábor, Gigler, János, Wellmann, Katalin, Nagy, István, Ling, József, Barkóczy, József, Haller, Jeremy J, Lambert, Gábor, Szénási, Michael, Spedding, Ferenc A, Antoni
Publikováno v:
Neuropharmacology. 125
Previous work has shown that S44819 is a novel GABAA receptor (GABA
Loop-F of the α-subunit determines the pharmacologic profile of novel competitive inhibitors of GABA
Autor:
Balázs, Mihalik, Adrienn, Pálvölgyi, Ferenc, Bogár, Katalin, Megyeri, István, Ling, József, Barkóczy, Ferenc, Bartha, Tamás A, Martinek, István, Gacsályi, Ferenc A, Antoni
Publikováno v:
European journal of pharmacology. 798
The neurotransmitter γ-amino butyric acid (GABA) has a fundamental role in CNS function and ionotropic (GABA
Autor:
Katalin Pallagi, György Lévay, Balázs Volk, József Barkóczy, Gyula Simig, Szabolcs Udvari, Kompagne Hajnalka, Andras Egyed, Michael Spedding, Laszlo G. Harsing, Istvan Gacsalyi, Tibor Mezei, Endre Hegedüs
Publikováno v:
Journal of Medicinal Chemistry. 51:2522-2532
A series of potent 5-hydroxytryptamine 7 (5-HT 7) ligands has been synthesized that contain a 1,3-dihydro-2 H-indol-2-one (oxindole) skeleton. The binding of these compounds to the 5-HT 7 and 5-HT 1A receptors was measured. Despite the structural sim
Autor:
Istvan Gacsalyi, Entire Hegedüs, Miklos Vegh, György Lévay, József Barkóczy, Kompagne Hajnalka, Gábor Kapus, Andras Bilkei-Gorzo, Laszlo G. Harsing, Csilla Leveleki
Publikováno v:
Psychopharmacology. 198:231-241
Although emerging number of data supports the role of glutamate receptors and the potential of their antagonists in anxiety disorders, the involvement of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors in anxiety is
Autor:
Gabor Gigler, Miklos Vegh, Szabolcs Kertesz, József Barkóczy, Annamária Simó, Angéla Benedek, Márta Ágoston, Geza Szabo, Marko Bernadett Martonne, Gábor Szénási, Istvan Gacsalyi, Gábor Kapus, Éva Matucz, Laszlo G. Harsing, György Lévay, Krisztina Moricz, Mihály Albert
Publikováno v:
British Journal of Pharmacology. 152:151-160
Background and purpose: Blockade of AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors is a good treatment option for a variety of central nervous system disorders. The present study evaluated the neuroprotective and anticonvulsan
Publikováno v:
Neurochemical Research. 29:1487-1497
Midbrain slices containing the dorsal and medial raphe nuclei were prepared from rat brain, loaded with [3H]serotonin ([3H]5-HT), superfused, and the electrically induced efflux of radioactivity was determined. The nonselective 5-HT receptor agonist